[0024] In the present invention, Fmoc-Lys(Alloc)-OH is used as a raw material, which simplifies the deprotection step, and eliminates the side reactions brought out during the deprotection of Mmt and Mtt, and the operation safety risk in removing Dde or ivDde protecting groups in the scale-up process
Injection site reactions (erythema, pruritus, swelling) occur in 1.4-2.4% of patients using subcutaneous formulations and are well-documented, localized effects
Besides this, may cause allergic reaction
Understanding vial concentrations Different pharmacy partners may provide different concentrations
If your blood glucose falls below 4.0 mmol/L, treat immediately with 1520g of fast-acting carbohydrate (such as glucose tablets, fruit juice, or sugary sweets), then recheck after 15 minutes, following NHS guidance on treating hypoglycaemia